Literature DB >> 22123909

Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity.

Keri B Sanborn1, Emily M Mace, Gregory D Rak, Analisa Difeo, John A Martignetti, Alessandro Pecci, James B Bussel, Rémi Favier, Jordan S Orange.   

Abstract

Natural killer (NK) cells are innate immune lymphocytes that provide critical defense against virally infected and transformed cells. NK-cell cytotoxicity requires the formation of an F-actin rich immunologic synapse (IS), as well as the polarization of perforin-containing lytic granules to the IS and secretion of their contents at the IS. It was reported previously that NK-cell cytotoxicity requires nonmuscle myosin IIA function and that granule-associated myosin IIA mediates the interaction of granules with F-actin at the IS. In the present study, we evaluate the nature of the association of myosin IIA with lytic granules. Using NK cells from patients with mutations in myosin IIA, we found that the nonhelical tailpiece is required for NK-cell cytotoxicity and for the phosphorylation of granule-associated myosin IIA. Ultra-resolution imaging techniques demonstrated that single myosin IIA molecules associate with NK-cell lytic granules via the nonhelical tailpiece. Phosphorylation of myosin IIA at residue serine 1943 (S1943) in the tailpiece is needed for this linkage. This defines a novel mechanism for myosin II function, in which myosin IIA can act as a single-molecule actin motor, claiming granules as cargo through tail-dependent phosphorylation for the execution of a pre-final step in human NK-cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123909      PMCID: PMC3228501          DOI: 10.1182/blood-2011-03-344846

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The human natural killer cell immune synapse.

Authors:  D M Davis; I Chiu; M Fassett; G B Cohen; O Mandelboim; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  A single class II myosin modulates T cell motility and stopping, but not synapse formation.

Authors:  Jordan Jacobelli; Stephen A Chmura; Denis B Buxton; Mark M Davis; Matthew F Krummel
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

3.  The mature activating natural killer cell immunologic synapse is formed in distinct stages.

Authors:  Jordan S Orange; K Eliza Harris; Milena M Andzelm; Markus M Valter; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

4.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

Authors:  K E Heath; A Campos-Barros; A Toren; G Rozenfeld-Granot; L E Carlsson; J Savige; J C Denison; M C Gregory; J G White; D F Barker; A Greinacher; C J Epstein; M J Glucksman; J A Martignetti
Journal:  Am J Hum Genet       Date:  2001-10-04       Impact factor: 11.025

5.  IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.

Authors:  Jordan S Orange; Sumita Roy-Ghanta; Emily M Mace; Saumya Maru; Gregory D Rak; Keri B Sanborn; Anders Fasth; Rushani Saltzman; Allison Paisley; Linda Monaco-Shawver; Pinaki P Banerjee; Rahul Pandey
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

6.  Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.

Authors:  S Kunishima; T Matsushita; T Kojima; N Amemiya; Y M Choi; N Hosaka; M Inoue; Y Jung; S Mamiya; K Matsumoto; Y Miyajima; G Zhang; C Ruan; K Saito; K S Song; H J Yoon; T Kamiya; H Saito
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

7.  Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.

Authors:  Jordan S Orange; Narayanaswamy Ramesh; Eileen Remold-O'Donnell; Yoji Sasahara; Louise Koopman; Michael Byrne; Francisco A Bonilla; Fred S Rosen; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Myosin II in retinal pigmented epithelial cells: evidence for an association with membranous vesicles.

Authors:  Laura A Linz-McGillem; Mark C Alliegro
Journal:  Exp Eye Res       Date:  2003-05       Impact factor: 3.467

9.  Myosin VI is required for E-cadherin-mediated border cell migration.

Authors:  Erika R Geisbrecht; Denise J Montell
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

10.  MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.

Authors:  Marco Seri; Alessandro Pecci; Filomena Di Bari; Roberto Cusano; Maria Savino; Emanuele Panza; Alessandra Nigro; Patrizia Noris; Simone Gangarossa; Bianca Rocca; Paolo Gresele; Nicola Bizzaro; Paola Malatesta; Pasi A Koivisto; Ilaria Longo; Roberto Musso; Carmine Pecoraro; Achille Iolascon; Umberto Magrini; Juan Rodriguez Soriano; Alessandra Renieri; Gian Marco Ghiggeri; Roberto Ravazzolo; Carlo L Balduini; Anna Savoia
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

View more
  33 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 2.  The heavy chain has its day: regulation of myosin-II assembly.

Authors:  Natalya G Dulyaninova; Anne R Bresnick
Journal:  Bioarchitecture       Date:  2013 Jul-Aug

Review 3.  Insights into primary immune deficiency from quantitative microscopy.

Authors:  Emily M Mace; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2015-06-13       Impact factor: 10.793

Review 4.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 5.  Blood and immune cell engineering: Cytoskeletal contractility and nuclear rheology impact cell lineage and localization: Biophysical regulation of hematopoietic differentiation and trafficking.

Authors:  Jae-Won Shin; Dennis E Discher
Journal:  Bioessays       Date:  2015-03-23       Impact factor: 4.345

Review 6.  Quantitative Imaging Approaches to Study the CAR Immunological Synapse.

Authors:  Malini Mukherjee; Emily M Mace; Alexandre F Carisey; Nabil Ahmed; Jordan S Orange
Journal:  Mol Ther       Date:  2017-06-26       Impact factor: 11.454

7.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

Review 8.  Mammalian nonmuscle myosin II comes in three flavors.

Authors:  Maria S Shutova; Tatyana M Svitkina
Journal:  Biochem Biophys Res Commun       Date:  2018-03-17       Impact factor: 3.575

9.  Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain.

Authors:  Xiong Liu; Shi Shu; Neil Billington; Chad D Williamson; Shuhua Yu; Hanna Brzeska; Julie G Donaldson; James R Sellers; Edward D Korn
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

10.  Proteome analysis of distinct developmental stages of human natural killer (NK) cells.

Authors:  Maxi Scheiter; Ulrike Lau; Marco van Ham; Björn Bulitta; Lothar Gröbe; Henk Garritsen; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2013-01-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.